Advisors
Scientific Advisory Board
Our Scientific Advisory Board includes thought leaders in the cancer research and therapeutics field. The willingness and enthusiasm from each of our SAB members to participate on this board further validates our therapeutic approach. Rigorous discussions and input will strengthen our product platform research and development. Members of our SAB include:
| David Bartlett, MD | University Pittsburgh Medical Center |
| Malcolm Brenner, MD, PhD | Baylor College of Medicine |
| William Dupere, MBA | Five Points Therapeutics, LLC |
| Douglas Hanahan, PhD | University of California, San Francisco |
| Terry Hermiston, PhD | Bayer HealthCare Pharmaceuticals |
| Thomas Lynch, MD, | Yale Comprehensive Cancer Center |
| Frank McCormick, PhD | University of California, San Francisco Helen Diller Family Comprehensive Cancer Center |
| Grant McFadden, PhD | University of Florida, College of Medicine |
| Paul Polakis, PhD | Genentech |
| Ramesh Shivdasani, MD, PhD | Dana Farber Cancer Institute |
Liver Cancer Advisory Board
We work closely with a group of experts in the liver cancer field in order for us to have the most up-to-date picture of the liver cancer market as we pursue the development of our lead product, JX-594, for liver cancer. We have strong representation from both North America and Asia on this board, and the members include:
| Ghassan K. Abou-Alfa, MD | Memorial Sloan-Kettering Cancer Center |
| Andrew Cheng, MD, PhD | National Taiwan University |
| Mong Cho, MD | Pusan National University |
| Hyun C Chung, MD, PhD | Yonsei University, Korea. |
| Jean Francois Geschwind, MD | Johns Hopkins University |
| Jeong Heo, MD, PhD | Pusan National University Hospital |
| Daniel Sze, MD, PhD | Stanford University |
| John E.L. Wong, MBBS, FAMS, FRCP, FACP |
Yong Loo Lin School of Medicine at the National University of Singapore |
| Alan Venook, MD | University of California, San Francisco. Professor, Department of Medicine, Hematology/Oncology |
| Riccardo Lencioni, MD | Pisa University Hospital in Italy, Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation |
| Ronnie Poon, MD | Professor of Surgery, the University of Hong Kong |
